Your browser doesn't support javascript.
loading
Spatial Transcriptomics Reveal Pitfalls and Opportunities for the Detection of Rare High-Plasticity Breast Cancer Subtypes.
Coutant, Angèle; Cockenpot, Vincent; Muller, Lauriane; Degletagne, Cyril; Pommier, Roxane; Tonon, Laurie; Ardin, Maude; Michallet, Marie-Cécile; Caux, Christophe; Laurent, Marie; Morel, Anne-Pierre; Saintigny, Pierre; Puisieux, Alain; Ouzounova, Maria; Martinez, Pierre.
Affiliation
  • Coutant A; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
  • Cockenpot V; Department of Pathology, Centre Léon Bérard, Lyon, France.
  • Muller L; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
  • Degletagne C; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
  • Pommier R; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France; Plateforme de bioinformatique Gilles Thomas, Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France.
  • Tonon L; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France; Plateforme de bioinformatique Gilles Thomas, Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France.
  • Ardin M; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France; Plateforme de bioinformatique Gilles Thomas, Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France.
  • Michallet MC; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
  • Caux C; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
  • Laurent M; Centre Léon Bérard, Lyon, France.
  • Morel AP; Centre Léon Bérard, Lyon, France.
  • Saintigny P; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France; Centre Léon Bérard, Lyon, France; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Puisieux A; Centre Léon Bérard, Lyon, France; Institut Curie, PSL Research University, Paris, France; Chemical Biology of Cancer Laboratory, CNRS UMR 3666, INSERM U1143, Paris, France.
  • Ouzounova M; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France. Electronic address: maria.ouzounova@lyon.unicancer.fr.
  • Martinez P; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France. Electronic address: pierre.martinez@lyon.unicancer.fr.
Lab Invest ; 103(12): 100258, 2023 12.
Article in En | MEDLINE | ID: mdl-37813278
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Triple Negative Breast Neoplasms Type of study: Diagnostic_studies Limits: Female / Humans Language: En Journal: Lab Invest Year: 2023 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Triple Negative Breast Neoplasms Type of study: Diagnostic_studies Limits: Female / Humans Language: En Journal: Lab Invest Year: 2023 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos